The global Polyanhydride Market, valued at US$ 42.7 million in 2023, is projected to expand at a CAGR of 8.3% through 2030, reaching an estimated valuation of US$ 74.1 million. This growth trajectory underscores the increasing adoption of polyanhydrides in biomedical applications, driven by their unique biodegradability and biocompatibility properties. The pharmaceutical and medical device...

North America represents a major market for hydrogel-based drug delivery systems due to its advanced healthcare infrastructure, substantial investments in pharmaceutical innovation, and rising focus on precision medicine. The region's growing demand for controlled-release therapies and patient-centric treatment approaches is expected to support continued market expansion. Hydrogel-Based Drug...

The United States represents a major contributor to the smart drug delivery system market, driven by advanced healthcare infrastructure, high adoption of connected medical devices, and the growing prevalence of chronic diseases such as diabetes and cardiovascular disorders. Increasing investments in digital health technologies and strong focus on patient-centered care continue to support the...